Publication | Closed Access
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion
30
Citations
0
References
2000
Year
PharmacologyPharmacokinetic StudyClinical PharmacologyPharmacotherapyDolastatin Analogue CemadotinMedicinePharmacokinetics
No additional data available for this publication yet. Check back later!